Multiple adaptive mechanisms to chronic liver disease revealed at early stages of liver carcinogenesis in the Mdr2-knockout mice

被引:70
作者
Katzenellenbogen, M
Pappo, O
Barash, H
Klopstock, N
Mizrahi, L
Olam, D
Jacob-Hirsch, J
Amariglio, N
Rechavi, G
Mitchell, LA
Kohen, R
Domany, E
Galun, E
Goldenberg, D
机构
[1] Hadassah Univ Hosp, Goldyne Savad Inst Gene Therapy, IL-91120 Jerusalem, Israel
[2] Hadassah Univ Hosp, Dept Pathol, IL-91120 Jerusalem, Israel
[3] Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, Jerusalem, Israel
[4] Tel Aviv Univ, Chaim Sheba Med Ctr, Inst Hematol, IL-69978 Tel Aviv, Israel
[5] Tel Aviv Univ, Chaim Sheba Med Ctr, Pediat Hematooncol Dept, IL-69978 Tel Aviv, Israel
[6] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel
关键词
D O I
10.1158/0008-5472.CAN-05-2937
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Molecular events preceding the development of hepatocellular carcinoma were studied in the Mdr2-knockout (Mdr2-KO) mice. These mice lack the liver-specific P-glycoprotein responsible for phosphatidylcholine transport across the canalicular membrane. Portal inflammation ensues at an early age followed by hepatocellular carcinoma development after the age of I year. Liver tissue samples of Mdr2-KO mice in the early and late precancerous stages of liver disease were subjected to histologic, biochemical, and gene expression profiling analysis. In an early stage, multiple protective mechanisms were found, including induction of many antiinflammatory and antioxidant genes and increase of total antioxidant capacity of liver tissue. Despite stimulation of hepatocyte DNA replication, their mitotic activity was blocked at this stage. In the late stage of the disease, although the total antioxidant capacity of liver tissue of Mdr2-KO mice was normal, and inflammation was less prominent, many protective genes remained overexpressed. Increased mitotic activity of hepatocytes resulted in multiple dysplastic nodules, some of them being steatotic. Expression of many genes regulating lipid and phospholipid metabolism was distorted, including up-regulation of choline kinase A, a known oncogene. Many other oncogenes, including cyclin D1, Jun, and some Ras tiontologues, were tip-regulated in Mdr2-KO mice at both stages of liver disease. However, we found no increase of Ras activation. Our data suggest that some of the adaptive mechanisms induced in the early stages of hepatic disease, which protect the liver from injury, could have an effect in hepatocarcinogenesis at later stages of the disease in this hepatocellular carcinoma model.
引用
收藏
页码:4001 / 4010
页数:10
相关论文
共 49 条
  • [1] Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1
    Benzeno, S
    Narla, G
    Allina, J
    Cheng, GZ
    Reeves, HL
    Banck, MS
    Odin, JA
    Diehl, JA
    Germain, D
    Friedman, SL
    [J]. CANCER RESEARCH, 2004, 64 (11) : 3885 - 3891
  • [2] Superparamagnetic clustering of data
    Blatt, M
    Wiseman, S
    Domany, E
    [J]. PHYSICAL REVIEW LETTERS, 1996, 76 (18) : 3251 - 3254
  • [3] HYDROLYSIS OF PHOSPHATIDYLCHOLINE COUPLES RAS TO ACTIVATION OF RAF PROTEIN-KINASE DURING MITOGENIC SIGNAL-TRANSDUCTION
    CAI, H
    ERHARDT, P
    TROPPMAIR, J
    DIAZMECO, MT
    SITHANANDAM, G
    RAPP, UR
    MOSCAT, J
    COOPER, GM
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (12) : 7645 - 7651
  • [4] COHEN SM, 1991, CANCER RES, V51, P6493
  • [5] Deane NG, 2001, CANCER RES, V61, P5389
  • [6] Secretory leukocyte protease inhibitor in cancer development
    Devoogdt, N
    Revets, H
    Ghassabeh, GH
    De Baetselier, P
    [J]. SIGNAL TRANSDUCTION AND COMMUNICATION IN CANCER CELLS, 2004, 1028 : 380 - 389
  • [7] Role of peroxisome proliferator-activated receptor γ and retinoid X receptor heterodimer in hepatogastroenterological diseases
    Dubuquoy, L
    Dharancy, S
    Nutten, S
    Pettersson, S
    Auwerx, J
    Desreumaux, P
    [J]. LANCET, 2002, 360 (9343) : 1410 - 1418
  • [8] Liver tumor development: c-Jun antagonizes the proapoptotic activity of p53
    Eferl, R
    Ricci, R
    Kenner, L
    Zenz, R
    David, JP
    Rath, M
    Wagner, EF
    [J]. CELL, 2003, 112 (02) : 181 - 192
  • [9] Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity
    Elad-Sfadia, G
    Haklai, R
    Balan, E
    Kloog, Y
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (33) : 34922 - 34930
  • [10] Galectin-1 augments Ras activation and diverts Ras signals to Raf-1 at the expense of phosphoinositide 3-kinase
    Elad-Sfadia, G
    Haklai, R
    Ballan, E
    Gabius, HJ
    Kloog, Y
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (40) : 37169 - 37175